z-logo
open-access-imgOpen Access
Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19 -associated CTCF-binding sites in colorectal cancer
Author(s) -
Hidewaki Nakagawa,
Robert B. Chadwick,
Païvi Peltomäki,
Christoph Plass,
Yusuke Nakamura,
Albert de la Chapelle
Publication year - 2000
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.98.2.591
Subject(s) - microsatellite instability , imprinting (psychology) , ctcf , dna methylation , biology , cpg site , genomic imprinting , cancer research , insulin like growth factor 2 , methylation , colorectal cancer , dna mismatch repair , microbiology and biotechnology , cancer , genetics , gene , transcription factor , microsatellite , allele , gene expression , enhancer
We hypothesize that loss of imprinting (LOI) of the insulin-like growth factor II (IGF2) gene is associated with a predisposition to sporadic colorectal cancer. We confirmed a previously known strong correlation between LOI and microsatellite instability and showed that LOI was not a consequence of microsatellite instability or mismatch repair deficiency. LOI of IGF2 correlated strongly with biallelic hypermethylation of a core of five CpG sites in the insulator region of IGF2/H19, which is a known CTCF-binding element. As this methylation-dependent LOI was present in both tumors and normal colonic mucosa, it is possible that hypermethylation creates a field defect predisposing to cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom